Unaudited Interim Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating activities
Net loss	$ (16,006)	$ (14,111)
Adjustments to reconcile net income to net cash provided by (used in) operating activities
Non-cash write downs of inventory	1,073	584
Accretion expense	(1,169)	(1,937)
Depreciation of property and equipment and amortization of intangible assets	5,085	3,521
Amortization of operating right-of-use assets	487	343
Share-based compensation	3,356	3,567
Deferred income tax (recovery) expense	(1,134)	224
(Gain) loss on fair value of warrants and purchase option derivative	(5,713)	5,410
Revaluation of contingent consideration	119	2,997
Release of indemnification asset	(25)	1,197
Forgiveness of principal and interest on loans		(766)
Unrealized and realized foreign exchange loss	356	2,783
Unrealized and realized loss (gain) on investments		(228)
Changes in operating assets and liabilities
Receivables	(1,399)	511
Inventory	3,706	(4,161)
Prepaid expense and deposits	682	294
Deposits	(593)
Other assets	571	(189)
Accounts payable and accrued liabilities and other payables	(12,475)	1,439
Operating lease liability	(271)	(81)
Other liability	(437)
Contingent consideration payable	(324)
Corporate income tax payable	4,869	4,713
Deferred revenue	395	102
Net cash (used in) provided by operating activities	(18,847)	6,212
Investing activities
Investment in property and equipment	(4,193)	(8,311)
Investment in intangible assets	(106)	(40)
Principal payments received on lease receivable	156	193
Distributions of earnings from associates		99
Deposits for property and equipment	(6,058)	(4,826)
Deposits for business acquisition	(602)
Cash received on acquisition of Gage	24,716
Net cash provided by (used in) investing activities	13,913	(12,885)
Financing activities
Proceeds from options and warrants exercised	23,925	9,170
Proceeds from loans payable		766
Capital contributions paid to non-controlling interests	(227)	(161)
Payments of contingent consideration	(6,630)
Proceeds from private placement, net of share issuance costs		173,477
Net cash provided by financing activities	17,068	183,252
Net (decrease) increase in cash and cash equivalents during the period	12,134	176,579
Net effects of foreign exchange	(3,369)	(1,568)
Cash and cash equivalents, beginning of period	79,642	59,226
Cash and cash equivalents, end of period	88,407	234,237
Supplemental disclosure with respect to cash flows
Income taxes paid	8	4,499
Interest paid	8,271	$ 9,140
Lease termination fee paid	3,300
Non-cash transactions
Shares issued as consideration for acquisitions	294,800
Shares issued for liability settlement	22
Accrued capital purchases	$ 56